Cancer

Misdirected funds could be undermining efforts to improve patient outcomes in regions that need it most.

The country was making a key contribution before Russia’s invasion.

From AI-enabled drug discovery to therapeutic vaccines, science is opening up fresh angles of attack against the disease.

A look at the key research institutions, funders and collaborations that are driving the field forward.

A zealous focus on discovery should not come at the expense of improving basic intervention.

Rising death rates are defying global trends but the continent’s researchers are keen to lead the fightback.

A description of the terminology and methodology used in this supplement, and a guide to the functionality that is available free online at natureindex.com.

Rapid advances in CAR-T-cell therapies and other personalized treatments mean that hospitals can now offer even more cleverly targeted cancer treatments.

An unparalleled bioresource bank and cutting-edge molecular and genomic techniques have put Japan’s National Cancer Center Research Institute at the forefront of cancer research.

A novel strategy that uses fibrous tissues around tumours to deliver high levels of drugs to cancer cells promises to boost treatment efficacy.

Singapore has become a centre for cancer clinical trials thanks to a pioneering genetic mutation identification programme that matches late-stage cancer patients to therapeutic studies.

From novel cancer-fighting microRNAs to new types of drug manufacturing facilities, Japan is breaking new ground in clinical research.

Early diagnosis of pancreatic cancer and a new way of treating hard-to-reach lung tumours are two ways that researchers in Japan are advancing on problematic cancers.

A drug originally developed for treating kidneys, turns out to be useful against cancer.

Japanese medical researchers are using world-leading robotics to provide minimally invasive gastric tract and prostate surgeries, and developing complex new organoids for personalized drug selection.

Preclinical discoveries are being rapidly translated due to close links between clinical trial teams and a cancer research institute.

Integrating three key cancer research areas is paving the way towards powerful therapies that help overcome treatment resistance.

How does University Medicine Zurich advance cutting-edge cancer research taking place across the city?

The molecular machinery of cancer must be explored to find effective new treatments. How do scientists at ONO PHARMA USA achieve this?

A surge in genetic testing is driving new research and improved care for those at high risk of hereditary cancer.